Last edition
News about Global Pharma
Avidity Biosciences' AOC 1044 Receives Rare Pediatric Disease Designation for DMD Treatment
AOC 1044, currently undergoing assessment in the Phase 1/2 EXPLORE44™ trial, is the first of multiple Antibody Oligonucleotide Conjugates (AOCs™) developed by Avidity for DMD.
Global Pharma | 21/02/2024 | By Manvi | 675
Thermo Fisher Scientific Receives Five Awards in Annual CDMO Leadership Awards
The awards, based on evaluations from customers who worked with contract manufacturers over the past 18 months, involved a rigorous assessment of 98 companies across 23 performance metrics.
Global Pharma | 20/02/2024 | By Manvi | 975
This agreement marks a pivotal step in Fusion's journey towards developing next-generation radiopharmaceuticals as precision medicines.
Global Pharma | 20/02/2024 | By Manvi | 733
Novartis AG Initiates Strategic Review of Novartis India Limited
While the strategic review progresses, it is essential to recognize that there is no guarantee of its completion within 2024.
Global Pharma | 19/02/2024 | By Manvi | 1262
PM Modi Lays Foundation Stone for AIIMS Rewari
Expressing his delight at the ceremony, PM Modi emphasized the rapid transformation of the healthcare sector in line with the aspirations of the people.
Global Pharma | 19/02/2024 | By Manvi | 665
CordenPharma and Pivot Energy Partners to Propel Renewable Energy Initiatives
Under the terms of the agreement, CordenPharma Colorado will tap into renewable energy generated by solar installations owned and operated by Pivot Energy.
Global Pharma | 16/02/2024 | By Manvi | 607
AMO Pharma's investigational oral glycogen synthase kinase 3 beta (GSK3β) inhibitor, in the treatment of genotype positive arrhythmogenic cardiomyopathy (ACM).
Global Pharma | 15/02/2024 | By Manvi | 773
Citius believes it has addressed enhanced product testing and additional manufacturing controls noted in the letter. There were no safety or efficacy issues cited and no additional trials required.
Global Pharma | 14/02/2024 | By Manvi | 691
Chanelle Pharma Acquired by Exponent, Marking a New Era
With over 730 employees across various locations, the company has established a strong foothold in Ireland, the UK, Europe, and Jordan.
Global Pharma | 14/02/2024 | By Manvi | 1181
Aurobindo Pharma Granted USFDA Approval for Deflazacort Tablets
The company plans to launch the product in February 2024.
Global Pharma | 14/02/2024 | By Manvi | 821
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy